Moreover, our study shows that NAT10 functions as a cancer-promoting molecule by targeting the glycolysis genes PFKM and LDHA directly or indirectly through acetylation in mRNA to reduce glycolysis breakdown and inhibit tumorigenesis. This evidence concerns the gene LDHA and cancer.